Indeed, SIRPα mediates inhibition that not only restrains macrophages from phagocytosis of tumor cells but also dampens their capacity to exert proinflammatory responses and immunogenic antigen presentation that drive antitumor adaptive immunity. Here, SIRPA is linked to neoplasm.